New AACI President Stanton Gerson Aims to Integrate Cancer Treatment Advances into the Community

Wednesday, January 25, 2017

Stanton L. Gerson, MD, recently became the new president of the Association of American Cancer Institutes during AACI’s annual meeting in Chicago, held October 23–25.

Dr. Gerson is the Asa and Patricia Shiverick – Jane Shiverick (Tripp) Professor of Hematological Oncology, Case Western Reserve University School of Medicine, director of the National Cancer Institute (NCI)-Designated Case Comprehensive Cancer Center, in Cleveland, OH, founding director of the National Center for Regenerative Medicine, and Distinguished University Professor at Case Western Reserve University. He is also director of University Hospitals Seidman Cancer Center in Cleveland and a member of the NCI Board of Scientific Advisors.

At the annual meeting, co-hosted by the Cancer Center Administrators Forum, Dr. Gerson launched his two-year term with a presentation outlining plans for his presidential initiative, which will address a major objective of the Obama Administration’s Cancer Moonshot initiative: Promoting collaborations with researchers, doctors and patients to improve patient outcomes and health care value in the community.